Tar­sus looks to raise aware­ness of eye­lid mite dis­ease in cam­paign aimed at eye­care spe­cial­ists

Eye­lid mite dis­ease may be “gross” but it’s al­so fair­ly com­mon, af­fect­ing about 25 mil­lion peo­ple in the US.

Called de­mod­ex ble­phar­i­tis, it’s a well-known con­di­tion among eye­care pro­fes­sion­als, but they of­ten don’t al­ways re­al­ize how com­mon it is. Tar­sus Phar­ma­ceu­ti­cals wants to change that with a new aware­ness cam­paign called “Look at the Lids.”

The cam­paign and web­site de­but Thurs­day — just three weeks af­ter Tar­sus filed for FDA ap­proval for a drug that treats the dis­ease.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.